USING OF BINOMINAL METHOD FOR THE PURPOSE OF DETERMINATION OF CONFIDENCE INTERVALS FOR PREDICTION OF INVASIVE DUCTAL BREAST CARCINOMA METASTASES

Alexandr Lazaruk, Igor Davydenko

Abstract


The study was performed using surgical and biopsy material based on histopathological study, which was conducted at the Chernivtsy Regional Clinical Oncology Centre. In the cases of verified diagnosis of ductal breast carcinoma was studied the size of the primary tumour node and metastasis in lymphogenous features of regional lymph node according to classification system TNM. All cases were divided by categories T and N. Using statistical data was conducted the analysis in patients of verified diagnosis of ductal breast carcinoma in Chernivtsy region. We determined the features of metastasis to regional lymph nodes under according to the classification pTNM and confidence intervals calculated according to percent binomial method with p=0.05. After receiving the results the data were compared to predict metastasis. Using statistical data were conducted the analysis in women of Chernivtsi region with verified diagnosis of ductal breast cancer. We determined the features of metastasis classification according pTNM and confidence intervals of percent according to binominal method with p=0.05. All observations of histopathological conclusions were conducted on the basis of Chernivtsy Regional Clinical Oncology Centre.


Keywords


ductal breast carcinoma; binominal method; predicting metastasis

Full Text:

PDF

References


Shapochka, D. O., Zalyetok, S. P., Hnydyuk, M. I. (2013). Molecular biological characteristics of breast cancer. Clinical Oncology, 2 (10), 138–142.

Sobin, L., Gospodarowicz, M., Wittekind, Ch. (Eds.) (2009). TNM Classification of Malignant Tumours. Seventh edition. WileyBlackwell, 328.

Lazaruk, A. V., Davydenko, I. (2014). Frequency of analysis ductal breast cancer according to the TNM classification in the Chernivtsi regional clinical oncology center at 2009–2013. Clinical and Experimental Pathology, XIII (2), 79–82.

Schurov, N. F., Paschenko, S. N., Voloshin, N. N. (2013). Clinical morphological characteristics of the tumour stroma in a patients with breast cancer. Zaporizhia state medical university. Oncology, 15 (4), 85–91.

Adams, S., Gray, R. J., Demaria, S., Goldstein, L., Perez, E. A., Shulman, L. N. et. al (2014). Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199. Journal of Clinical Oncology, 32 (27), 2959–2966. doi: 10.1200/jco.2013.55.0491

Boroday, N. V., Lukyanova, N. Y. (2007). Hereditary breast cancer: clinical, morphological and biological characteristics. Oncology, 9 (2), 105–109.

Anitei, M.-G., Zeitoun, G., Mlecnik, B., Marliot, F., Haicheur, N., Todosi, A.-M. et. al (2014). Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer. Clinical Cancer Research, 20 (7), 1891–1899. doi: 10.1158/1078-0432.ccr-13-2830

Choi, C. H., Kang, H., Kim, W. Y., Kim, T.-J., Lee, J.-W., Huh, S. J. et. al (2008). Prognostic Value of Baseline Lymphocyte Count in Cervical Carcinoma Treated With Concurrent Chemoradiation. International Journal of Radiation Oncology*Biology*Physics, 71 (1), 199–204. doi: 10.1016/j.ijrobp.2007.09.024

Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R. et. al (2008). Cancer survival in five continents: a worldwide population-based study (CONCORD). The Lancet Oncology, 9 (8), 730–756. doi: 10.1016/s1470-2045(08)70179-7

Dabbs, D. J. (2010). Diagnostic immunohistochemistry: theranostic and genomic applications. Philadelphia: Saunders Elsevier Science, 941.

Ferlay, J., Shin, H.-R., Bray, F., Forman, D., Mathers, C., Parkin, D. M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127 (12), 2893–2917. doi: 10.1002/ijc.25516

Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thurlimann, B., Senn, H.-J. (2011). Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Annals of Oncology, 22 (8), 1736–1747. doi: 10.1093/annonc/mdr304

Gos, M., Miłoszewska, J., Przybyszewska, M. (2009). Epithelial-mesenchymal transition in cancer progression. Postepy Biochem, 55 (2), 121–128.

Hugo, H., Ackland, M. L., Blick, T., Lawrence, M. G., Clements, J. A., Williams, E. D., Thompson, E. W. (2007). Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. Journal of Cellular Physiology, 213 (2), 374–383. doi: 10.1002/jcp.21223

Loi, S., Michiels, S., Salgado, R., Sirtaine, N., Jose, V., Fumagalli, D. et. al (2014). Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. Annals of Oncology, 25 (8), 1544–1550. doi: 10.1093/annonc/mdu112

Mohammed, Z. M., Going, J. J., Edwards, J., Elsberger, B., Doughty, J. C., McMillan, D. C. (2012). The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. British Journal of Cancer, 107 (5), 864–873. doi: 10.1038/bjc.2012.347

Park, S. Y., Gönen, M., Kim, H. J., Michor, F., Polyak, K. (2010). Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. Journal of Clinical Investigation, 120 (2), 636–644. doi: 10.1172/jci40724

Tot, T. (2014). Breast Cancer Subgross Morphological Parameters and Their Relation to Molecular Phenotypes and Prognosis. The Journal of OncoPathology, 2 (4), 69–76. doi: 10.13032/tjop.2052-5931.100106

Smolanka, I. I., Sklar, S. Y., Dosenko, I. I. (2009). Prevention and early diagnosis of breast cancer. SI “National Cancer Institute of Medical Sciences of Ukraine” Female Doctor, 5, 40–45.




DOI: http://dx.doi.org/10.21303/2504-5679.2016.00090

Refbacks

  • There are currently no refbacks.


Bookmark and Share


Copyright (c) 2016 Alexandr Lazaruk, Igor Davydenko

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)